CurveBeam AI Limited (ASX:CVB)
Australia · Delayed Price · Currency is AUD 0.0220
0.00 (0.00%)
Oct 7, 2026, 1:45 PM AEST
CurveBeam AI Market Cap
CurveBeam AI has a market cap or net worth of 16.9 million as of October 7, 2026. That makes CurveBeam AI the world's 40,731st most valuable company and 1,160th in Australia. Its market cap has decreased by 61.15% in one year.
Market Cap
16.90M
Enterprise Value
32.91M
Revenue
8.67M
Global Rank
Country Rank
#1,160 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 23, 2023, CurveBeam AI's market cap has decreased from 108.85M to 16.90M, a decrease of -84.48%. That is a compound annual growth rate of -44.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 16.90M | -51.19% |
| Dec 31, 2025 | 34.62M | -34.20% |
| Dec 31, 2024 | 52.62M | -60.39% |
| Dec 29, 2023 | 132.86M | 22.06% |
| Aug 23, 2023 | 108.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 49.82M |
| Cleo Diagnostics | 47.99M |
| Micro-X | 41.38M |
| CleanSpace Holdings | 38.89M |
| Nova Eye Medical | 37.75M |
| Control Bionics | 34.76M |
| OncoSil Medical | 27.53M |
| ImpediMed | 18.31M |